ClinicalTrials.gov
public full text
Public Domain
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
This is a randomized, single-blind, placebo-controlled, parallel-group, multicentre study in patients with CAD. The study will be conducted at approximately 10 centres in 3 countries. Approximately 138 CAD patients will be randomized to AZD5718 or placebo (treatment duration 12 weeks).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent#1029750
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation#894615
- Pharmacist CVD Intervention for Patients With Inflammatory Arthritis#1151908
- LIFESTAT - Living With Statins, a Cross Sectional Study#968966
- Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent#854889
Record · ID 884479
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive